Modernas PR wins again. In a Dow Jones release the company said they went on full alarm last Tuesday when information on the Omicron variant was noticed. Well, BNTX has been working for months expecting just such an occurrence, yet Moderna, a US company was the feature stating they could have a solution by 2022s first quarter end. Once again the market reacts to a PR with scant detail and ignores data presented earlier by Pfizer/BNTX. That’s not new. Both will rise but it seems twisted.

$BioNTech SE(BNTX)$ $Moderna, Inc.(MRNA)$ $Pfizer(PFE)$